The Enterprise Value as of November 2024 (TTM) for Sage Therapeutics, Inc. (SAGE) is 296.65M

According to Sage Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 296.65M. This represents a change of -61.22% compared to the average of 764.93M of the last 4 quarters.

Sage Therapeutics, Inc. (SAGE) Historical Enterprise Value (quarterly & annually)

How has SAGE Enterprise Value performed in the past?

The mean historical Enterprise Value of Sage Therapeutics, Inc. over the last ten years is 2.58B. The current 296.65M Enterprise Value has changed 1.05% with respect to the historical average. Over the past ten years (40 quarters), SAGE's Enterprise Value was at its highest in in the June 2019 quarter at 9.29B. The Enterprise Value was at its lowest in in the September 2024 quarter at 351.91M.

Sage Therapeutics, Inc. (SAGE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sage Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sage Therapeutics, Inc. (SAGE) Average Enterprise Value

How has SAGE Enterprise Value performed in the past?

The current Enterprise Value of Sage Therapeutics, Inc. (SAGE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sage Therapeutics, Inc. (SAGE) Enterprise Value vs. Peers

How is SAGE’s Enterprise Value compared to its peers?

Sage Therapeutics, Inc.’s Enterprise Value is less than Apellis Pharmaceuticals, Inc. (3.37B), less than Terns Pharmaceuticals, Inc. (525.14M), less than Day One Biopharmaceuticals, Inc. (1.23B), less than Blueprint Medicines Corporation (6.70B), less than Cerevel Therapeutics Holdings, Inc. (8.24B), less than Mirati Therapeutics, Inc. (3.91B), less than Amylyx Pharmaceuticals, Inc. (386.88M), less than Relay Therapeutics, Inc. (904.72M), less than Stoke Therapeutics, Inc. (583.03M), less than Pliant Therapeutics, Inc. (892.62M), greater than Black Diamond Therapeutics, Inc. (182.15M), less than Arvinas, Inc. (1.78B), less than Krystal Biotech, Inc. (5.36B), less than Alnylam Pharmaceuticals, Inc. (35.99B), less than Madrigal Pharmaceuticals, Inc. (7.42B), less than Incyte Corporation (14.79B), less than Reata Pharmaceuticals, Inc. (6.68B), greater than DiaMedica Therapeutics Inc. (170.14M), less than Akero Therapeutics, Inc. (2.08B), less than Nuvalent, Inc. (6.58B), less than Immunocore Holdings plc (1.29B), greater than Ventyx Biosciences, Inc. (104.74M),

Build a custom stock screener for Sage Therapeutics, Inc. (SAGE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sage Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sage Therapeutics, Inc. (SAGE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sage Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.